Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 49, Issue 11, 2008, Pages 2133-2140

  Koharazawa, Hideyuki ^a,b   Kanamori, Heiwa ^c   Sakai, Rika ^d   Hashimoto, Chizuko ^c   Takemura, Sachiya ^e   Hattori, Michiko ^f   Taguchi, Jun ^b   Fujimaki, Katsumichi ^a,e   Tomita, Naoto ^a   Fujita, Hiroyuki ^a   Fujisawa, Shin ^d   Harano, Hiroshi ^g   Ogawa, Koji ^g   Motomura, Shigeki ^c   Maruta, Atsuo ^c   Ishigatsubo, Yoshiaki ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIZUOKA RED CROSS HOSPITAL   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

^d YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^e Fujisawa City Hospital   (Japan)

^f Yokohama Ekisaikai Hospital   (Japan)

^g Yokosuka City Hospital   (Japan)

Author keywords

Acute lymphoblastic leukemia; Anthracycline; Philadelphia chromosome; Prognostic factors

Indexed keywords

ASPARAGINASE; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; HEMOGLOBIN; HYDROCORTISONE; LACTATE DEHYDROGENASE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PIRARUBICIN; PREDNISOLONE; THIOTEPA; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLAST CELL; CANCER CLASSIFICATION; CANCER SURVIVAL; CLINICAL PROTOCOL; DIARRHEA; DISEASE FREE SURVIVAL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG RESPONSE; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN BLOOD LEVEL; HEPATOSPLENOMEGALY; HUMAN; ILEUS; INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHILADELPHIA 1 CHROMOSOME; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; VOMITING;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISOLONE; PROGNOSIS; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 57049135789     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802464711     Document Type: Article

References (26)

1. Hoelzer, D., Thiel, E., Löffler, H., Buchner, T., Gansner, A. Heil, G. et al. (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood, 71, pp. 123-131.
2. Larson, R. A., Dodge, R. K., Bums, C. P., Lee, E. J., Stone, R. M. Schulman, P. et al. (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood, 85, pp. 2025-2037.
3. Kantarjian, H. M., O'Brien, S., Smith, T. L., Cortes, J., Giles, F. J. Beran, M. et al. (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol, 18, pp. 547-561.
4. Petersdorf, S. H., Kopecky, K. J., Head, D. R., Boldt, D. H., Balcerzak, S. P. Wun, T. et al. (2001) Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/ L-asparaginase for adult acute lymphoblastic leukemia: A Southwest Oncology Group Study. Leukemia, 15, pp. 208-216.
5. Annino, L., Vegan, M. L., Camera, A., Specchia, G., Visani, G. Fioritoni, G. et al. (2002) Treatment of adult acute lymphoblastic leukemia (ALL): Long-term follow-up of the GIMEMA ALL0288 randomized study. Blood, 99, pp. 863-871.
6. Linker, C., Damon, L., Ries, C. and Navarro, W. (2002) Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol, 20, pp. 2464-2471.
7. Hunault, M., Harousseau, J. L., Delain, M., Truchan-Graczyk, M., Cahn, J. Y. Witz, F. et al. (2004) Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after high-dose therapy and autologous BMT. a GOELAMS trial. Blood, 104, pp. 3028-3037.
8. Rowe, J. M., Buck, G., Burnett, A. K., Chopra, R., Wiemik, P. H. Richards, S. M. et al. (2005) Induction therapy for adult acute lymphoblastic leukemia: Results of more than 1500 patients from the international ALL trial: MRC UKALL XIII/ECOG E2993. Blood, 106, pp. 3760-3767.
9. Thomas, X., Boiron, J. M., Huguet, F., Dombret, H., Bradstock, K. Vey, N. et al. (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trial. J Clin Oncol, 22, pp. 4075-4086.
10. Schrappe, M., Reiter, S., Ludwig, W. D., Harbott, J., Zimmermann, M. Hiddemann, W. et al. (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM90. German-Austrian-Swiss ALL BFM Study Group. Blood, 95, pp. 3310-3322.
11. Silverman, L. B., Gelber, R. D., Dalton, V. K., Asselin, B. L., Barr, R. D. Clavell, L. A. et al. (2001) Improved outcome for children with acute lymphoblastic leukemia: Results of Dana Faber consortium protocol 91-01. Blood, 97, pp. 1211-1218.
12. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. Gralnick, H. R. et al. (1976) Proposals for the classification of the acute leukaemias: French-American-British (FAB) Co-operative Group. Br J Haematol, 33, pp. 451-458.
13. Bassan, R., Lerede, T., Rambaldi, A., Di Bona, E, Rossi, G. Pogliani, E. et al. (1996) The role of anthracyclines in adult acute lymphoblastic leukemia. Leukemia, 10, pp. S58-S61.
14. Bassan, R., Battista, R., D'Emilio, A., Viero, P., Dragone, P. Dini, E. et al. (1991) Long-term results of the HEAV'D protocol for adult acute lymphoblastic leukaemia. Eur J Cancer, 27, pp. 441-447.
15. Goldstone, A. H., Richards, S. M., Lazarus, H. M., Tallman, M. S., Buck, G. Fielding, A. K. et al. (2008) In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: Final results of the international ALL Trial (MRC UKALL XII/ECOG E2993). Blood, 111, pp. 1827-1833.
16. Secker-Walker, L. M., Prentice, H. G., Durrant, J., Richards, S., Hall, E. and Harrison, G. (1997) Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukemia on MRC trial UKALL XA-MRC Adult Leukaemia Working Party. Br J Haematol, 96, pp. 601-610.
17. Wetzler, M., Dodge, R. K., Mrosek, K., Carroll, A. J., Tantravahi, R. Block, A. W. et al. (1999) Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience. Blood, 93, pp. 3983-3993.
18. Gleissner, B., Gokbuget, N., Bartram, C. R., Janssen, B., Rieder, H. Janssen, J WG et al. (2002) Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: A prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood, 99, pp. 1536-1543.
19. +ALL). Blood, 108, pp. 1469-1477.
20. Yanada, M., Takeuchi, J., Sugimura, I., Akiyama, H., Usui, N. Yagasaki, F. et al. (2006) High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: A phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol, 24, pp. 460-466.
21. Delannoy, A., Delabesse, E., Lheritier, V., Castaigne, S., Rigal-Huguet, F. Raffoux, E. et al. (2006) Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: Results of the GRAALL AFR09 study. Leukemia, 20, pp. 1526-1532.
22. Boissel, N., Auclerc, M. F., Lheritier, V., Perel, Y., Thomas, X. Leblanc, T. et al. (2003) Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol, 21, pp. 774-780.
23. Ueda, T., Miyawaki, S., Asou, N., Kuraishi, Y., Hiraoka, A. Kuriyama, K. et al. (1998) Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: ALL-90 study of the Japan Adult Leukemia Study Group. Int J Hematol, 68, pp. 279-289.
24. Hatta, Y., Takeuchi, J., Ohshima, T., Horikoshi, A., Iizuka, Y. Kawamura, M. et al. (2001) Analysis of 20-year follow-up study of LVP regimen for adult acute lymphoblastic leukemia. Int J Hematol, 74, pp. 157-164.
25. Ng, S. M., Lin, H. P., Ariffin, W. A., Zainab, A. K., Lam, S. K. and Chan, L. L. (2000) Age, sex, haemoglobin level, and white cell count at diagnosis are important prognostic factors in children with acute lymphoblastic leukemia treated with BFM-type protocol. J Trop Pediatr, 46, pp. 338-343.
26. Bassan, R., Lerede, T., Rambaldi, A., Di Bona, E, Rossi, G. Pogliani, E. et al. (1996) The role of anthracyclines in adult acute lymphoblastic leukaemia. Leukemia, 10, pp. S58-S61.